share_log

180 Life Sciences | CORRESP: CORRESP

180 Life Sciences | CORRESP: CORRESP

180 Life Sciences | CORRESP:信函
美股SEC公告 ·  02/07 22:20
Moomoo AI 已提取核心信息
180 Life Sciences Corp. has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Form S-1 Registration Statement, as per a letter dated February 7, 2024. The company has proposed for the Registration Statement to become effective at 11:00 a.m. Eastern Standard Time on February 9, 2024. This request was made under Rule 461 of the Securities Act of 1933, as amended. The SEC has been asked to take the necessary action to meet the requested timeline. David M. Loev of The Loev Law Firm, PC is the contact person for any inquiries regarding this acceleration request.
180 Life Sciences Corp. has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Form S-1 Registration Statement, as per a letter dated February 7, 2024. The company has proposed for the Registration Statement to become effective at 11:00 a.m. Eastern Standard Time on February 9, 2024. This request was made under Rule 461 of the Securities Act of 1933, as amended. The SEC has been asked to take the necessary action to meet the requested timeline. David M. Loev of The Loev Law Firm, PC is the contact person for any inquiries regarding this acceleration request.
根据2024年2月7日的一封信,180生命科学公司已正式要求美国证券交易委员会(SEC)加快其S-1表格注册声明的生效日期。该公司已提议注册声明于美国东部标准时间2024年2月9日上午11点生效。该请求是根据经修订的1933年《证券法》第461条提出的。美国证券交易委员会已被要求采取必要行动以满足要求的时间表。如果您对本加速请求有任何疑问,PC Loev Law Firm 的 David M. Loev 是联系人。
根据2024年2月7日的一封信,180生命科学公司已正式要求美国证券交易委员会(SEC)加快其S-1表格注册声明的生效日期。该公司已提议注册声明于美国东部标准时间2024年2月9日上午11点生效。该请求是根据经修订的1933年《证券法》第461条提出的。美国证券交易委员会已被要求采取必要行动以满足要求的时间表。如果您对本加速请求有任何疑问,PC Loev Law Firm 的 David M. Loev 是联系人。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息